Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Aug 31, 2025 | (Q2)May 31, 2025 | (Q1)Feb 28, 2025 | (FY)Nov 30, 2024 | (Q4)Nov 30, 2024 | (Q3)Aug 31, 2024 | (Q2)May 31, 2024 | (Q1)Feb 29, 2024 | (FY)Nov 30, 2023 | (Q4)Nov 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 64.74%-17.23K | -15.69%-132.44K | 18.25%-73.26K | -7.20%-284.41K | 42.35%-31.44K | -79.96%-48.88K | 4.50%-114.48K | -40.60%-89.61K | 28.52%-265.32K | -48.10%-54.55K |
| Net income from continuing operations | -95.16%-87.69K | -6.78%-90.3K | -49.56%-96.92K | 36.96%-275.95K | 33.34%-81.65K | 57.84%-44.93K | -14.72%-84.56K | 51.98%-64.81K | 77.62%-437.76K | 92.19%-122.48K |
| Asset impairment expenditure | --0 | --0 | --37.8K | --0 | --0 | --0 | --0 | --0 | -97.55%36.12K | -98.99%14.74K |
| Remuneration paid in stock | --14.39K | 325.56%19.11K | -93.89%771 | -84.03%17.11K | --0 | --0 | -79.44%4.49K | -4.26%12.62K | -44.05%107.17K | -19.31%24.57K |
| Other non cashItems | ---- | ---- | ---- | -50.42%-20K | --0 | --0 | --0 | -866.18%-20K | 64.21%-13.3K | 75.30%-8.67K |
| Change In working capital | 1,521.63%56.07K | -78.01%-61.26K | 14.48%-14.9K | -113.14%-5.58K | 34.59%50.2K | -113.09%-3.94K | 48.91%-34.41K | -141.11%-17.42K | 198.91%42.45K | -55.10%37.3K |
| -Change in receivables | 103.08%34.6K | -65.56%-31.36K | -190.62%-5.02K | -88.00%5.73K | -89.75%2.1K | 236.75%17.04K | -433.88%-18.94K | -87.20%5.54K | 214.75%47.69K | -44.86%20.45K |
| -Change in payables and accrued expense | 202.35%21.47K | -93.26%-29.9K | 56.95%-9.88K | -115.44%-11.3K | 185.55%48.11K | -149.27%-20.98K | 75.76%-15.47K | -2,563.34%-22.96K | -287.44%-5.25K | -63.35%16.85K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 64.74%-17.23K | -15.69%-132.44K | 18.25%-73.26K | -7.20%-284.41K | 42.35%-31.44K | -79.96%-48.88K | 4.50%-114.48K | -40.60%-89.61K | 28.52%-265.32K | -48.10%-54.55K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 14.96%-197.44K | 95.97%-5.71K | 94.80%-12.45K | 51.40%-619.41K | 96.78%-5.86K | 48.53%-232.18K | -123.70%-141.78K | 58.53%-239.59K | 8.34%-1.27M | 74.77%-182.21K |
| Net PPE purchase and sale | 9.62%-137.22K | --0 | 60.15%-9.99K | 62.87%-126.88K | 453.98%50K | 48.30%-151.82K | --0 | -2,406.10%-25.06K | -9.20%-341.73K | 88.26%-14.13K |
| Net other investing changes | 25.06%-60.22K | 95.97%-5.71K | 98.85%-2.46K | 47.20%-492.53K | 66.77%-55.86K | 48.98%-80.36K | -366.06%-141.78K | 62.81%-214.53K | 13.44%-932.78K | 72.08%-168.08K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 14.96%-197.44K | 95.97%-5.71K | 94.80%-12.45K | 51.40%-619.41K | 96.78%-5.86K | 48.53%-232.18K | -123.70%-141.78K | 58.53%-239.59K | 8.34%-1.27M | 74.77%-182.21K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 22.90%353.74K | -110.89%-9.89K | 24.51%199.21K | -40.59%531.48K | -101.51%-7.16K | -31.73%287.84K | 90.8K | 160K | -58.58%894.64K | 473.04K |
| Net issuance payments of debt | --0 | --0 | --0 | ---40K | --0 | --0 | --0 | ---40K | --0 | --0 |
| Net common stock issuance | 16.67%350K | --0 | --200K | -33.33%600K | --0 | --300K | --300K | --0 | -58.92%900K | --900K |
| Net other financing activities | 130.70%3.74K | 95.27%-9.89K | -100.40%-791 | -432.18%-28.53K | 98.32%-7.16K | ---12.17K | ---209.2K | --200K | 82.73%-5.36K | ---426.96K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 22.90%353.74K | -110.89%-9.89K | 24.51%199.21K | -40.59%531.48K | -101.51%-7.16K | -31.73%287.84K | --90.8K | --160K | -58.58%894.64K | --473.04K |
| Net cash flow | ||||||||||
| Beginning cash position | -55.58%57.73K | -30.35%205.76K | -80.14%92.26K | -58.14%464.61K | -40.12%136.72K | -54.41%129.95K | -36.92%295.41K | -58.14%464.61K | 55.92%1.11M | -87.78%228.32K |
| Current changes in cash | 1,953.20%139.06K | 10.53%-148.04K | 167.08%113.51K | 42.29%-372.35K | -118.82%-44.46K | 111.94%6.77K | 9.71%-165.46K | 73.63%-169.2K | -262.10%-645.19K | 131.13%236.29K |
| End cash Position | 43.93%196.79K | -55.58%57.73K | -30.35%205.76K | -80.14%92.26K | -80.14%92.26K | -40.12%136.72K | -54.41%129.95K | -36.92%295.41K | -58.14%464.61K | -58.14%464.61K |
| Free cash from | 23.04%-154.45K | -15.69%-132.44K | 27.41%-83.24K | 24.01%-461.3K | 54.21%-31.44K | 37.44%-200.7K | 25.09%-114.48K | -77.14%-114.67K | 11.27%-607.05K | 56.30%-68.67K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.